Paper39562
Neocarzinostatin: spectral characterization and separation of a non-protein chromophore.
Napier MA and 3 others. Biochem Biophys Res Commun, 1979. Cited by 131 papers, by iCite.
Cite this record
ConductScience Library. Neocarzinostatin: spectral characterization and separation of a non-protein chromophore. Papers, record 39562. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39562
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibiotics, Antineoplastic | Major topic |
| Zinostatin | Major topic |
| Circular Dichroism | |
| Hydrogen-Ion Concentration | |
| Ligands | |
| Spectrometry, Fluorescence | |
| Spectrophotometry | |
| Spectrophotometry, Ultraviolet |
Source PubMed
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 131 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 23322746 | Evaluating the use of Apo-neocarzinostatin as a cell penetrating protein. | Protein Eng Des Sel | 2013 | https://conductscience.org/library/papers/23322746 | PubMed |
| 16593156 | Identification of thymidine-5'-aldehyde at DNA strand breaks induced by neocarzinostatin chromophore. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/16593156 | PubMed |
| 15821162 | Cold instability of aponeocarzinostatin and its stabilization by labile chromophore. | Biophys J | 2005 | https://conductscience.org/library/papers/15821162 | PubMed |
| 11562456 | Gene transcription analysis of Saccharomyces cerevisiae exposed to neocarzinostatin protein-chromophore complex reveals evidence of DNA damage, a potential mechanism of resistance, and consequences of prolonged exposure. | Proc Natl Acad Sci U S A | 2001 | https://conductscience.org/library/papers/11562456 | PubMed |
| 8439978 | The role of monoclonal antibody A7 as a drug modifier in cancer therapy. | Cancer Immunol Immunother | 1993 | https://conductscience.org/library/papers/8439978 | PubMed |
| 8276723 | Production, binding and cytotoxicity of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate. | Jpn J Cancer Res | 1993 | https://conductscience.org/library/papers/8276723 | PubMed |
| 7340987 | DNA breakage activity of the methanol extract of auromomycin. | Cancer Chemother Pharmacol | 1981 | https://conductscience.org/library/papers/7340987 | PubMed |
| 6445563 | Roles of chromophore and apo-protein in neocarzinostatin action. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6445563 | PubMed |
| 3158880 | Activation of neocarzinostatin chromophore and formation of nascent DNA damage do not require molecular oxygen. | Nucleic Acids Res | 1985 | https://conductscience.org/library/papers/3158880 | PubMed |
| 2951653 | A tentative model of the intercalative binding of the neocarzinostatin chromophore to double-stranded tetranucleotides. | Nucleic Acids Res | 1987 | https://conductscience.org/library/papers/2951653 | PubMed |
| 2935786 | Mode of reversible binding of neocarzinostatin chromophore to DNA: base sequence dependency of binding. | Nucleic Acids Res | 1986 | https://conductscience.org/library/papers/2935786 | PubMed |
| 2933140 | Selective toxicity of neocarzinostatin-monoclonal antibody conjugates to the antigen-bearing human melanoma cell line in vitro. | Cancer Immunol Immunother | 1985 | https://conductscience.org/library/papers/2933140 | PubMed |
| 2480846 | Stimulation of non-specific resistance to tumors in the mouse using a poly(maleic-acid-styrene)-conjugated neocarzinostatin. | Cancer Immunol Immunother | 1989 | https://conductscience.org/library/papers/2480846 | PubMed |
| 2140808 | Specific cytotoxic effect of neocarzinostatin conjugated to monoclonal antibody A7 on human pancreatic carcinoma. | Gastroenterol Jpn | 1990 | https://conductscience.org/library/papers/2140808 | PubMed |
| 2139934 | Molecular models of neocarzinostatin damage of DNA: analysis of sequence dependence in 5'GAGCG:5'CGCTC. | Nucleic Acids Res | 1990 | https://conductscience.org/library/papers/2139934 | PubMed |
| 1924343 | Studies on DNA-cleaving agents: computer modeling analysis of the mechanism of activation and cleavage of dynemicin-oligonucleotide complexes. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1924343 | PubMed |
| 1826561 | Selective abstraction of 2H from C-5' of thymidylate in an oligodeoxynucleotide by the radical center at C-6 of the diradical species of neocarzinostatin: chemical evidence for the structure of the activated drug-DNA complex. | Proc Natl Acad Sci U S A | 1991 | https://conductscience.org/library/papers/1826561 | PubMed |
| 1531835 | Targeted enhancement of the biological activity of the antineoplastic agent, neocarzinostatin. Studies in murine neuroblastoma cells. | J Clin Invest | 1992 | https://conductscience.org/library/papers/1531835 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39562
GET https://conductscience.org/api/papers/v1/39562/authors